Skip to content
Centre de référence des microangiopathies thrombotiques
Accessibilité
800x600 Résolution intermédiaire Plein écran Augmenter la taille des caractères Réduire la taille des caractères Taille des caractères par défaut
Bannière
Bannière

Articles médicaux - 2019

PDFImprimerEmail
Écrit par Paul Coppo
ARTICLES EN ANGLAIS
Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. Knoebl P, Cataland S, Peyvandi F, Coppo P, Scully M, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Minkue Mi Edou J, De Winter H, Callewaert F. J Thromb Haemost. 2020 Feb;18(2):479-484. doi: 10.1111/jth.14679. Epub 2019 Dec 9. PMID: 31691462; PMCID: PMC7027866.
Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature. Elessa D, Talbot A, Lombion N, Harel S, Galicier L, Veyradier A, Joly B, Andreoli A, Rigaudeau S, Azoulay É, Coppo P, Royer B, Arnulf B. Br J Haematol. 2020 Jan;188(2):338-340. doi: 10.1111/bjh.16333. Epub 2019 Dec 15. PMID: 31840243.
Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura. O. Garraud, S. Malot, R. Herbrecht, et al. Transfus Apher Sci. 2019 Dec;58(6):102665.
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival. Prevel R, Roubaud-Roubaud C, Gourlain S, Jamme M, et al. Blood. 2019 Sep 17.
Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura. Béranger N, Benghezal S, Savigny S, Capdenat S, et al. Thromb Res. 2019 Jul 16;181:29-35.
Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients. Schelpe AS, Roose E, Joly BS, Pareyn I, et al. Haematologica. 2019 Jun;104(6):1268-1276.
Transfer of ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura via kidney transplantation. Zafrani L, Dekimpe C, Joly BS, Roose E, et al. Haematologica. 2019 Jun;104(6):e277-e280.
Inherited Thrombotic Thrombocytopenic Purpura Revealed by Recurrent Strokes in a Male Adult: Case Report and Literature Review. Beauvais D, Venditti L, Chassin O, Joly B, Ameri A, Boisseau P, Lambotte O, Coppo P, Veyradier A, Denier C. J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1537-1539.
Thrombotic microangiopathy associated with anti-neutrophil cytoplasmic antibody-associated vasculitis: a French nationwide retrospective case-control study and literature review. Dellal A, Bige N, Hilliquin P, Boffa JJ, et al. Rheumatology (Oxford). 2019 Apr 28.
Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers. Meibody F, Jamme M, Tsatsaris V, Provot F, et al. Nephrol Dial Transplant. 2019 Feb 25.
Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort. Daviet F, Rouby F, Poullin P, Moussi-Francès J, Sallée M, Burtey S, Mancini J, Duffaud F, Sabatier R, Pourroy B, Grandvuillemin A, Grange S, Frémeaux-Bacchi V, Coppo P, Micallef J, Jourde-Chiche N. Br J Clin Pharmacol 2019;85:403-12.
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. M. Scully, SR. Cataland, F. Peyvandi, P. Coppo, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators. N Engl J Med 2019;380:335-46.
Mis à jour le 24 Novembre 2020

Le CNR-MAT souhaite vous offrir la meilleure expérience possible sur son site. En poursuivant votre navigation, vous acceptez l’utilisation des cookies permettant d'étudier l’audience du site et de vous proposer du contenu et des services adaptés à votre intérêt pour les MAT. Pour en savoir plus, consultez notre politique cookies

J'accepte les cookies sur ce site